Rituximab, age and high dose therapy followed by autologus stem cell transplantation are independent prognostic factors for survival in the first line treatment of primary CNS-lymphoma
Gespeichert in:
| Weitere Verfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Konferenzschrift |
| Sprache: | Englisch |
| Veröffentlicht: |
2014
|
| In: |
Blood
Year: 2014, Jahrgang: 124, Heft: 21 |
| ISSN: | 1528-0020 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://ash.confex.com/ash/2014/webprogram/Paper68919.html/
|
| Verfasserangaben: | Michael Madle, Isabelle Herth, Nicola Lehners, Mark-Alexander Schwarzbich, Patrick Wuchter, Gerlinde Egerer, Anthony D. Ho, Mathias Witzens-Harig |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1504796802 | ||
| 003 | DE-627 | ||
| 005 | 20221123114606.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150702s2014 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1504796802 | ||
| 035 | |a (DE-576)434796808 | ||
| 035 | |a (DE-599)BSZ434796808 | ||
| 035 | |a (OCoLC)1340701135 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Rituximab, age and high dose therapy followed by autologus stem cell transplantation are independent prognostic factors for survival in the first line treatment of primary CNS-lymphoma |c Michael Madle, Isabelle Herth, Nicola Lehners, Mark-Alexander Schwarzbich, Patrick Wuchter, Gerlinde Egerer, Anthony D. Ho, Mathias Witzens-Harig |
| 264 | 1 | |c 2014 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.07.2015 | ||
| 700 | 1 | |a Madle, Michael |d 1984- |0 (DE-588)107327490X |0 (DE-627)828794995 |0 (DE-576)434796425 |4 oth | |
| 700 | 1 | |a Krämer, Isabelle |d 1984- |0 (DE-588)1025613481 |0 (DE-627)723627738 |0 (DE-576)370555724 |4 oth | |
| 700 | 1 | |a Giesen, Nicola |d 1983- |0 (DE-588)141844272 |0 (DE-627)631828524 |0 (DE-576)32643657X |4 oth | |
| 700 | 1 | |a Schwarzbich, Mark-Alexander |d 1983- |0 (DE-588)143268236 |0 (DE-627)64435867X |0 (DE-576)335999263 |4 oth | |
| 700 | 1 | |a Wuchter, Patrick |d 1975- |0 (DE-588)123450284 |0 (DE-627)082563624 |0 (DE-576)184642574 |4 oth | |
| 700 | 1 | |a Egerer, Gerlinde |0 (DE-588)105502168X |0 (DE-627)792516745 |0 (DE-576)167430882 |4 oth | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 oth | |
| 700 | 1 | |a Witzens-Harig, Mathias |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 oth | |
| 773 | 0 | 8 | |i In |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 124(2014,21) Artikel-Nr. 68919, 1 S. |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Rituximab, age and high dose therapy followed by autologus stem cell transplantation are independent prognostic factors for survival in the first line treatment of primary CNS-lymphoma |
| 773 | 1 | 8 | |g volume:124 |g year:2014 |g number:21 |g extent:1 |a Rituximab, age and high dose therapy followed by autologus stem cell transplantation are independent prognostic factors for survival in the first line treatment of primary CNS-lymphoma |
| 856 | 4 | 0 | |u https://ash.confex.com/ash/2014/webprogram/Paper68919.html/ |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20150702 | ||
| 993 | |a ConferencePaper | ||
| 994 | |a 2014 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 8 |y j | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 105502168X |a Egerer, Gerlinde |m 105502168X:Egerer, Gerlinde |d 910000 |d 910100 |e 910000PE105502168X |e 910100PE105502168X |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 123450284 |a Wuchter, Patrick |m 123450284:Wuchter, Patrick |d 910000 |d 910100 |e 910000PW123450284 |e 910100PW123450284 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 143268236 |a Schwarzbich, Mark-Alexander |m 143268236:Schwarzbich, Mark-Alexander |d 910000 |d 910100 |e 910000PS143268236 |e 910100PS143268236 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 141844272 |a Giesen, Nicola |m 141844272:Giesen, Nicola |d 910000 |d 910100 |e 910000PG141844272 |e 910100PG141844272 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1025613481 |a Krämer, Isabelle |m 1025613481:Krämer, Isabelle |d 910000 |d 910100 |e 910000PK1025613481 |e 910100PK1025613481 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 107327490X |a Madle, Michael |m 107327490X:Madle, Michael |d 50000 |e 50000PM107327490X |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1504796802 |e 2847499717 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"1 S."}],"relHost":[{"disp":"Rituximab, age and high dose therapy followed by autologus stem cell transplantation are independent prognostic factors for survival in the first line treatment of primary CNS-lymphomaBlood","note":["Gesehen am 21.04.2023"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"266886647","language":["eng"],"corporate":[{"role":"isb","display":"American Society of Hematology","roleDisplay":"Herausgebendes Organ"}],"pubHistory":["1.1946 -"],"titleAlt":[{"title":"Blood online"}],"part":{"issue":"21","year":"2014","extent":"1","text":"124(2014,21) Artikel-Nr. 68919, 1 S.","volume":"124"},"title":[{"subtitle":"journal of the American Society of Hematology","title":"Blood","title_sort":"Blood"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1946-","dateIssuedKey":"1946","publisher":"American Society of Hematology ; Saunders ; HighWire Press","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif."}],"id":{"issn":["1528-0020"],"zdb":["1468538-3"],"eki":["266886647"]}}],"origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"id":{"eki":["1504796802"]},"name":{"displayForm":["Michael Madle, Isabelle Herth, Nicola Lehners, Mark-Alexander Schwarzbich, Patrick Wuchter, Gerlinde Egerer, Anthony D. Ho, Mathias Witzens-Harig"]},"note":["Gesehen am 02.07.2015"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1504796802","title":[{"title_sort":"Rituximab, age and high dose therapy followed by autologus stem cell transplantation are independent prognostic factors for survival in the first line treatment of primary CNS-lymphoma","title":"Rituximab, age and high dose therapy followed by autologus stem cell transplantation are independent prognostic factors for survival in the first line treatment of primary CNS-lymphoma"}],"person":[{"family":"Madle","given":"Michael","display":"Madle, Michael","role":"oth"},{"family":"Krämer","given":"Isabelle","display":"Krämer, Isabelle","role":"oth"},{"role":"oth","display":"Giesen, Nicola","given":"Nicola","family":"Giesen"},{"role":"oth","display":"Schwarzbich, Mark-Alexander","given":"Mark-Alexander","family":"Schwarzbich"},{"family":"Wuchter","given":"Patrick","display":"Wuchter, Patrick","role":"oth"},{"role":"oth","display":"Egerer, Gerlinde","given":"Gerlinde","family":"Egerer"},{"family":"Ho","given":"Anthony Dick","display":"Ho, Anthony Dick","role":"oth"},{"family":"Witzens-Harig","given":"Mathias","display":"Witzens-Harig, Mathias","role":"oth"}]} | ||
| SRT | |a RITUXIMABA2014 | ||